California Schools Try Rap While Scores Keep Falling

Lilly Slides After New Obesity Pill Prescription Data Disappoints Wall Street Shares of Eli Lilly & Co. fell in New York premarket trading after new industry prescription data for the drugmaker's blockbuster obesity shot Zepbound and recently approved oral weight-loss pill Foundayo disappointed Wall Street analysts. Foundayo generated 3,707 prescriptions in its second week, according to new prescription-tracking data from IQVIA cited by RBC Capital Markets analysts. That compares with 18,410 prescriptions for Novo's oral version of Wegovy during its second week after launch, suggesting Lilly's weight-loss drugs are falling behind...

Tens Of Millions Of Taxpayers May Be Owed IRS Refunds From Pandemic Era: Watchdog Authored by Jack Phillips via The Epoch Times (emphasis ours), The IRS’s internal watchdog has stated that tens of millions of U.S. taxpayers may be owed refunds or abatements of penalties or interest during the COVID-19 federal disaster period. A 1040 Internal Revenue Service tax form, in this file photo. Madalina Kilroy/The Epoch Times “The bottom line: You may be entitled to a refund or reduction of assessed penalties and interest,” the National Taxpayer Advocate (NTA) stated in a...

"Massive Culling" Imminent For Alt Managers, Soros Fund CEO Warns Authored by Lance Roberts via RealInvestmentAdvice.com, Dawn Fitzpatrick says overallocated LPs, frozen distributions, and mounting margin-call risk are converging into a sector-wide shakeout. Such will eventually separate survivors from the casualties. I used Claude to source data on private credit and equity funds, sources disclosed at the end. In July 2024, I penned an article entitled “Private Equity: Why Am I So Lucky,” which began with: “Lately, I have been getting many questions about investing in private equity. Such is common during raging bull markets, as individuals seek higher rates...